US Stock MarketDetailed Quotes

ACRV Acrivon Therapeutics

Watchlist

6.550
+0.110+1.71%

Close Nov 22 16:00 ET

6.550
0.0000.00%

Post 16:02 ET

203.94MMarket Cap-2462P/E (TTM)

Acrivon Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Acrivon Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 0.000	--
--	2024/Q4	-- / 0.000	--
--	2024/Q3	0.000 / 0.000	--
--	2024/Q2	0.000 / 0.000	--
--	2024/Q1	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 0.000--

--2024/Q4-- / 0.000--

--2024/Q30.000 / 0.000--

--2024/Q20.000 / 0.000--

--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

Acrivon Therapeutics Earnings Reports

Acrivon Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 13 07:08 ET

Acrivon Therapeutics | 8-K: Acrivon Therapeutics Reports Third Quarter 2024 Financial Results and Business Highlights

Nov 13 07:03 ET

Acrivon Therapeutics | 8-K: Acrivon Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights

Aug 13 08:02 ET

Acrivon Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 13 07:42 ET

Analyst Rating

Updated: Nov 14, 2024

Strong Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall